Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3093434rdf:typepubmed:Citationlld:pubmed
pubmed-article:3093434lifeskim:mentionsumls-concept:C0995343lld:lifeskim
pubmed-article:3093434lifeskim:mentionsumls-concept:C0003693lld:lifeskim
pubmed-article:3093434lifeskim:mentionsumls-concept:C0085385lld:lifeskim
pubmed-article:3093434lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:3093434lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:3093434pubmed:issue8lld:pubmed
pubmed-article:3093434pubmed:dateCreated1986-11-7lld:pubmed
pubmed-article:3093434pubmed:abstractTextPseudomonas methanica KY4634 was found to produce 5-lipoxygenase inhibitor designated KF8940, MY12-62a and MY12-62c. The inhibitors were purified by solvent extraction, silica gel column chromatography, reversed-phase low pressure liquid chromatography and crystallization. The chemical structures of KF8940, MY12-62a and MY12-62c were determined to be 2-n-heptyl-4-hydroxyquinoline-N-oxide, 2-n-heptyl-4-hydroxyquinoline and 3-n-heptyl-3-hydroxy-1,2,3,4-tetrahydroquinoline-2,4-dione, respectively, on the basis of their physico-chemical properties. Among them, KF8940 was the most potent inhibitor. The compound inhibited 5-lipoxygenase of rat basophilic leukemia cells in a dose-dependent manner and the half maximal inhibitory concentration (IC50) was 1.5 X 10(-7) M. At this concentration, KF8940 did not inhibit bovine platelet 12-lipoxygenase and cyclooxygenase, and the IC50 values for these enzyme were 3.5 X 10(-5) M and 1.7 X 10(-4) M, respectively. The results indicated that KF8940 is a potent and selective inhibitor of 5-lipoxygenase. The IC50 value of MY12-62c for 5-lipoxygenase was 1.9 X 10(-5) M and that of MY12-62a was 1.9 X 10(-5) M.lld:pubmed
pubmed-article:3093434pubmed:languageenglld:pubmed
pubmed-article:3093434pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093434pubmed:citationSubsetIMlld:pubmed
pubmed-article:3093434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093434pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3093434pubmed:statusMEDLINElld:pubmed
pubmed-article:3093434pubmed:monthAuglld:pubmed
pubmed-article:3093434pubmed:issn0021-8820lld:pubmed
pubmed-article:3093434pubmed:authorpubmed-author:HashizumeKKlld:pubmed
pubmed-article:3093434pubmed:authorpubmed-author:KitamuraSSlld:pubmed
pubmed-article:3093434pubmed:authorpubmed-author:MANNS JSJlld:pubmed
pubmed-article:3093434pubmed:authorpubmed-author:ShirahataKKlld:pubmed
pubmed-article:3093434pubmed:authorpubmed-author:MiyashitaEElld:pubmed
pubmed-article:3093434pubmed:authorpubmed-author:KastWWlld:pubmed
pubmed-article:3093434pubmed:issnTypePrintlld:pubmed
pubmed-article:3093434pubmed:volume39lld:pubmed
pubmed-article:3093434pubmed:ownerNLMlld:pubmed
pubmed-article:3093434pubmed:authorsCompleteYlld:pubmed
pubmed-article:3093434pubmed:pagination1160-6lld:pubmed
pubmed-article:3093434pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:3093434pubmed:meshHeadingpubmed-meshheading:3093434-...lld:pubmed
pubmed-article:3093434pubmed:meshHeadingpubmed-meshheading:3093434-...lld:pubmed
pubmed-article:3093434pubmed:meshHeadingpubmed-meshheading:3093434-...lld:pubmed
pubmed-article:3093434pubmed:meshHeadingpubmed-meshheading:3093434-...lld:pubmed
pubmed-article:3093434pubmed:meshHeadingpubmed-meshheading:3093434-...lld:pubmed
pubmed-article:3093434pubmed:meshHeadingpubmed-meshheading:3093434-...lld:pubmed
pubmed-article:3093434pubmed:meshHeadingpubmed-meshheading:3093434-...lld:pubmed
pubmed-article:3093434pubmed:year1986lld:pubmed
pubmed-article:3093434pubmed:articleTitleStudies on lipoxygenase inhibitors. II. KF8940 (2-n-heptyl-4-hydroxyquinoline-N-oxide), a potent and selective inhibitor of 5-lipoxygenase, produced by Pseudomonas methanica.lld:pubmed
pubmed-article:3093434pubmed:publicationTypeJournal Articlelld:pubmed